Pulmonary (Lung/Respiratory Tract) Disease
Show Only Open Trials
1.
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis (RAINIER)
- Study Status: Open to Enrollment
- Sponsor: Gilead
- Disease Status and/or Stage: Idiopathic Pulmonary Fibrosis (IPF)
2.
A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects
- Study Status: Open to Enrollment
- Sponsor: ACTG
- Protocol ID: A5295
3.
The Natural History of Gene Expression in Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and Disease
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
4.
Evaluation of the Lungs of Normal (Smokers, Ex-smokers, Non-Smokers) Individuals with Segmental Bronchopulmonary Lung Lavage, Bronchial Brushing, and Bronchial Wall Biopsy
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
5.
6.
PANTHER Study (Prednisone, Azathioprine, and N-acetylcysteine: A Study That Evaluates Response in IPF)
- Study Status: Closed to Enrollment
- Sponsor: IPFnet/NIH
- Disease Status and/or Stage: Idiopathic Pulmonary Fibrosis (IPF)
7.
ACE-IPF Study (AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis)
- Study Status: Closed to Enrollment
- Sponsor: IPFnet/NIH
- Disease Status and/or Stage: Idiopathic Pulmonary Fibrosis (IPF)
8.
Modulation of Arachidonic Acid Metabolism by Chemopreventive Agents in Smokers
- Study Status: Closed to Enrollment
- Sponsor: National Cancer Institute/Division of Cancer Prevention (NCI/DCP)
